REVISTA CHILENA DE ENFERMEDADES RESPIRATORIAS

223

de Chile-2014.

http://web.minsal.cl/sites/default/files/ NORMA_TECNICA_TUBERCULOSIS.pdf

. (Consul-

tado el 15 septiembre de 2015).

9.-

HANSEL N N,

MERRIMAN B,

HAPONIK E F

DIETTE G B

. Hospitalizations for tuberculosis in the

United States in 2000: predictors of in-hospital mortali-

ty. Chest 2004; 126: 1079-86.

10.- PEPPER D J, SCHOMAKER M, WILKINSON R J,

DE AZEVEDO V, AND MAARTENS G. Independent

predictors of tuberculosis mortality in a high HIV pre-

valence setting: a retrospective cohort study.

AIDS Res Ther

2015; 12: 35.

11.- LUBART E, LIDGI M, LEIBOVITZ A, RABINOVITZ

C, SEGAL R. Mortality of Patients Hospitalized for

Active Tuberculosis in Israel. IMAJ 2007; 9: 870-3.

12.- SILVA D R, MENEGOTTO D M, SCHULZ L F,

GAZZANA M B, DALCIN P T R. Clinical charac-

teristics and evolution of non-HIV-infected immuno-

compromised patients with an in-hospital diagnosis of

tuberculosis. J Bras Pneumol 2010; 36: 475-84.

13.- CHUQUIYAURI R, VERDONCK K, GONZÁLES E,

ZAMUDIO E, ECHEVARRIA J, SEAS C, et al. Morbi-

mortalidad de pacientes con tuberculosis hospitalizados

en el Departamento de enfermedades infecciosas, tropi-

cales y dermatológicas del Hospital Nacional Cayetano

Heredia, Lima - Perú entre los años 1990 y 2000. Rev

Med Hered [online] 2004; 15 :203-10.

14.- RAO V K, IADEMARCO E P, FRASER V J,

KO- LLEF M H.

The Impact of Comorbidity on Mortality

Following In-hospital Diagnosis of Tuberculosis. Chest

1998; 114: 1244- 52.

15-

SMALL P M,

FUJIWARA P I.

Management of tuber-

culosis in the United States.

N Engl J Med

2001; 345:

189-200.

16.-

ABDOOL KARIM S S,

NAIDOO K,

GROBLER A,

PADAYATCHI N

BAXTER C,

GRAY A,

et al.

Timing of initiation of antiretroviral drugs during tu-

berculosis therapy.

N Engl J Med

2010; 362: 697-706.

17.- CHARLSON M E, POMPEI P, ALES K L,

MA CKENZIE C R.

A new method of classifying prognostic

comorbidity in longitudinal studies: development and

validation. J Chronic Dis 1987; 40: 373-83.

18.-

TANG S,

TAN S, YAO L,

LI F, LI L, GUO X,

et al.

Risk factors for poor treatment outcomes in patients

with MDR-TB and XDR-TB in China: retrospective

multi-center investigation.

PLoS One

2013; 8: e82943.

Correspondencia a:

Dr. Francisco Arancibia

Instituto Nacional del Tórax,

Avda. José M. Infante 717, Providencia.

Santiago de Chile

Email:

fearancibia@gmail.com

19.-

GETAHUN B, AMENI G, BIADGILIGN S, MEDHIN G.

Mortality and associated risk factors in a cohort of

tuberculosis patients treated under DOTS programme in

Addis Abeba, Ethiopia.

BMC Infect Dis

2011; 16; 11:

127.

20.- MANDELL L A, WUNDERINK R G , ANZUETO A,

BARTLETT J G, CAMPBELL G D, DEAN N C,

et al;

Infectious Diseases Society of America; American Tho-

racic Society . Infectious Diseases Society of America/

American Thoracic Society consensus guidelines on

the management of community acquired pneumonia in

adults. Clin Infect Dis 2007; 44 (suppl 2): S27-S72 .

21.- RUDRAJIT P. State of the Globe: Immune Thrombo-

cytopenia, an Uncommon Complication in Tuberculosis.

J Glob Infect Dis

2014; 6:93-4.

22.- DAGAONKAR R S, UDWADIA Z F. Disseminated

tuberculosis with immune thrombocytopenic purpura.

Lung India 2012; 29: 63-5.

23.- BOOTS R J, ROBERTS A W, MCEVOY D. Immune

thrombocytopenia complicating pulmonary tuberculosis:

case report and investigation of mechanisms. Thorax

1992; 47: 396-7.

24.-

ROLLAS K, KARA A

ORTAÇ ERSOY N E

ÖZMEN SÜNER K, GÜLLÜ MN, ÖCAL S,

et al. Acute tuber-

culosis in the intensive care unit.

Turk J Med Sci

2015;

45: 882-7.

25.-

ERBES R, OETTEL K, RAFFENBERG M, MAUCH H,

SCHMIDT-IOANAS M,

LODE H.

Characteristics

and outcome of patients with active pulmonary tuber-

culosis requiring intensive care.

Eur Respir J

2006; 27:

1223-8.

26.-

DALE K, TAY E, TREVAN P, DENHOLM J T.

Mor-

tality among tuberculosis cases in Victoria, 2002-2013:

case fatality and factors associated with death.

Int J Tuberc Lung Dis

2016; 20: 515-23.

27.-

HEUNIS J C, KIGOZI N G, CHIKOBVU P, BOTHA S, VAN RENSBURG HD.

Risk factors for mortality in TB

patients: a 10-year electronic record review in a South

African province.

BMC Public Health

2017; 17: 38.

28.- Organización Panamericana de la Salud. La tubercu-

losis en la Región de las Américas: Informe Regio-

nal 2012. Epidemiología, control y financiamiento.

Washington, DC: OPS, 2013.

http://www.paho.org /hq/index.php?option=com_docman&task=doc_ view&gid=22954&Itemid=270.

(Consultado el 29 de

diciembre de 2016).

Rev Chil Enferm Respir 2016; 32: 217-223

Letalidad y sobrevida de pacientes con tuberculosis hospitalizados en el inT